Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT

Cancer immunotherapy: moving beyond current vaccines

Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo · Nature Medicine · 2004 · 3K citations · Full text

Vaccination, Tumor Immunology, Cancer Immunosurveillance +9

Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism

David H. Munn, Min Zhou, John T. Attwood et al. · Science · 1998 · 2.6K citations

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Catherine Uyttenhove, Luc Pilotte, Ivan Théate et al. · Nature Medicine · 2003 · 2.3K citations

Inflammation, Cancer Immunosurveillance, Biochemistry +8

Modulation of tryptophan catabolism by regulatory T cells

Francesca Fallarino, Ursula Grohmann, Kwang Woo Hwang et al. · Nature Immunology · 2003 · 1.3K citations

Signal Transduction, T-regulatory Cell, Immunology +7

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy

Alexander J. Muller, James B. DuHadaway, Preston S. Donover et al. · Nature Medicine · 2005 · 1.1K citations

Oncology, Oncogenic Agent, Medicine +8